Objectives
Intraductal papillary mucinous neoplasms (IPMNs) are cystic precursor lesions to pancreatic cancer. The presence of oral microbes in pancreatic tissue or cyst fluid has been associated with high-grade dysplasia (HGD) and cancer. The present study aims at investigating if humoral immunity to pancreas-associated oral microbes reflects IPMN severity.
Design
Paired plasma (
n
= 109) and saliva (
n
= 65) samples were obtained from IPMN pancreatic cystic tumor cases and controls, for anti-bacterial antibody analysis and DNA quantification by enzyme-linked immunosorbent assay (ELISA) and qPCR, respectively. Tumor severity was graded by histopathology, laboratory, and clinical data. Circulating plasma and salivary antibody reactivity to a pancreas-associated oral microbe panel were measured by ELISA and correlated to tumor severity.
Results
The patient group with high-risk cystic tumors (HGD and/or associated invasive cancer) shows ample circulating IgG reactivity to
Fusobacterium nucleatum
(
F. nucleatum
) but not to
Granulicatella adiacens
(
G. adiacens
), which is independent of the salivary bacteria DNA levels. This group also shows higher salivary IgA reactivity to
F. nucleatum
, Fap2 of
F. nucleatum
, and
Streptococcus gordonii
(
S. gordonii
) compared to low-risk IPMN and controls. The salivary antibody reactivity to
F. nucleatum
and Fap2 are found to be highly correlated, and cross-competition assays further confirm that these antibodies appear cross-reactive.
Conclusion
Our findings indicate that humoral reactivity against pancreas-associated oral microbes may reflect IPMN severity. These findings are beneficial for biomarker development.